ADXS31-142
Prostate Cancer
Prostate Specific Antigen (PSA) is the basis of the common blood test used to indicate the presence of prostate cancer. It is an antigen that is currently being used by many companies in the development of prostate specific therapies. A Listeria construct containing a PSA-LLO fusion protein has been developed using our newest strain of Listeria, and has been shown to be stable and very effective in animal models of prostate cancer.
